HALO: Halozyme Inc. P/S multiplikatori

Halozyme Corp (HALO) tovar belgisi

Halozyme Therapeutics (HALO) uchun narx/savdo koeffitsiyenti Halozyme Therapeutics (HALO) ning baholash dinamikasini aks ettiradi, bunda 6.30 joriy ko'rsatkichni ifodalaydi. Biznes modeli ferment ishlab chiqarishni uchinchi tomon pudratchilariga autsorsing qilishga asoslangan. Daromadlar dori vositalarini yetkazib berish huquqlarini global ishtirokchilarga sotish orqali diversifikatsiya qilingan. ENHANZE platformasining yuqori marjalari kapitalning barqaror oqimini ta'minlab, uning texnologik yechimlari dolzarbligini tasdiqlaydi.

Halozyme Inc. - HALO Narxning daromadga nisbati (davr: 04.07.2022 - 16.11.2026)

Halozyme Therapeutics, Inc. (HALO) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning fundamental tahlili:HALO (Halozyme)
Halozyme yetakchi tovari

P/S koeffitsiyenti bozor kapitalizatsiyasini yillik savdo hajmi bilan solishtiradi va bu foydadan qat'i nazar, daromadning har bir birligi uchun to'langan premiumni baholash imkonini beradi. Kompaniya qiymatining yillik daromadga nisbatini tahlil qilish orqali investor o'sish premiumi asoslangan yoki asoslanmaganligini aniqlaydi, bu esa Halozyme Therapeutics (HALO) uchun litsenziyalash royaltilarini kengaytirish va minimal operatsion xarajatlar bilan ferment texnologiyalarini monetizatsiya qilishda hal qiluvchi ahamiyatga ega.

Raqobatdosh kompaniyalar

ONC - Sotuvga nisbatan narx|P/S multiplikatori RVMD (revmed.com)|Narx/daromad koeffitsiyenti Ascentage (AAPG)|CGON: Kapitalizatsiyaning daromadga nisbati|Sotuvga nisbatan narx UroGen Pharma Ltd.|BCAX: P/S multiplikatori|PSNL - Narx/daromad koeffitsiyenti|ERAS (Erasca Oncology) - P/S multiplikatori|P/S multiplikatori Delcath Systems, Inc.|Narxning daromadga nisbati ymabs.com (YMAB)|Narxning daromadga nisbati AURA (Aura Biosciences, Inc.)|Candel Therapeutics - Kapitalizatsiyaning daromadga nisbati|Accuray Inc. (ARAY) - Sotuvga nisbatan narx|SELLAS Life Sciences Group, Inc. - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ACTU (Actuate Therapeutics, Inc.)|Citius Oncology (CTOR) - Narxning daromadga nisbati|HURA - Narx/daromad koeffitsiyenti|TARA (Protara Therapeutics, Inc.) - P/S multiplikatori|P/S multiplikatori Fate Therapeutics Inc|P/S multiplikatori WHWK|P/S multiplikatori TScan Therapeutics Inc (TCRX)|Narxning daromadga nisbati championsoncology.com CSBR|XBIT - Kapitalizatsiyaning daromadga nisbati|CVM - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati OSTX (OS Therapies)|RADX: P/S multiplikatori|Artiva Biotherapeutics Inc. - Bozor kapitallashuvining daromadga nisbati|ANL (Adlai Nortye) - P/S multiplikatori|P/S multiplikatori verupharma.com|Kapitalizatsiyaning daromadga nisbati TPST (tempesttx.com)|Kapitalizatsiyaning daromadga nisbati Xilio Therapeutics Inc XLO|P/S multiplikatori RENB (Enochian BioSciences)|Mural Bio - Narxning daromadga nisbati|KAPA - Narxning daromadga nisbati|OnKure Therapeutics (OKUR) - Kapitalizatsiyaning daromadga nisbati|GDTC: P/S multiplikatori|Sotuvga nisbatan narx Curis Corp (CRIS)|APLM (apollomicsinc.com) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Tharimmune Corp (THAR)|P/S multiplikatori ADVB|GNPX - Sotuvga nisbatan narx|Narxning daromadga nisbati calidibio.com CLDI|SBFM - Kapitalizatsiyaning daromadga nisbati|XBIO - Narxning daromadga nisbati|SLRX: Narxning daromadga nisbati|Purple Biotech (PPBT) - Narxning daromadga nisbati|AON - Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati BGNE|P/S multiplikatori Checkpoint Therapeutics Inc.|P/S multiplikatori ELEV|Kapitalizatsiyaning daromadga nisbati iCAD ICAD|P/S multiplikatori IKNA (Ikena Oncology, Inc.)|Bozor kapitallashuvining daromadga nisbati NTBL|Viracta Therapeutics, Inc. - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati MOR (MorphoSys Inc)|NAYA (NAYA Biosciences Inc) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Ascentage Pharma Group Ltd